On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

An iconic annual gift catalog known for its extravagance has removed the word "Christmas" from its name after a nearly 100-year run. Neiman Marcus' "Christmas Book," in print since 1926 ...

Neiman Marcus has quietly removed the word “Christmas” from its iconic, 98-year-old annual gift catalog – and some company insiders gripe that the stealthy switch smacks of woke politics ...

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation ...

Abstract: Magnetically steerable endovascular guidewire robotic systems that are capable of automatic agile navigation have great potential for medical applications, such as endovascular ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...

Erica Denhoff / Icon Sportswire via Getty Images Boston Scientific shares fell Wednesday as its third-quarter profit missed estimates. The medical device maker's adjusted earnings per share and ...

Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be ...

Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ...

Core Scientific is expanding its AI deal with CoreWeave. Russell Cann, Core Scientific’s chief development officer, talked to CoinDesk about the particulars of the bitcoin miner’s multi ...